SMI 12’087 0.1%  SPI 15’534 0.1%  Dow 35’085 0.4%  DAX 15’640 0.5%  Euro 1.0772 -0.1%  EStoxx50 4’117 0.3%  Gold 1’828 1.2%  Bitcoin 35’848 -1.6%  Dollar 0.9059 -0.5%  Öl 75.9 1.5% 

GlaxoSmithKline Aktie 1102657 / GB0009252882

17.81
CHF
-0.77
CHF
-4.15%
18:00:00
BRX

Aktionärsstruktur

Inhaber in %
Freefloat 98.06
Government Pension Fund - Global (The) 2.49
Dodge & Cox International Stock Fund 1.70
Vanguard Total International Stock Index Fund 1.23
Capital Income Builder 1.14
Caisse de Dépôt & Placement du Québec 1.06

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2016 2017 2018 2019 2020
Personal am Ende des Jahres 99’300 98’462 95’490 99’437 94’066
Umsatz pro Mitarbeiter in Mio. EUR 0.28 0.31 0.32 0.34 0.36

Bilanz (in Mio. EUR) - Aktiva

2016 2017 2018 2019 2020
Summe Umlaufvermögen 16’711 15’907 16’927 19’491 20’247
Summe Anlagevermögen 19’914 17’021 30’424 41’913 41’737
Summe Aktiva 59’081 56’381 58’066 79’692 80’431

Bilanz (in Mio. EUR) - Passiva

2016 2017 2018 2019 2020
Gesamtverschuldung/ -verbindlichkeiten 18’790 17’089 26’064 30’508 27’150
Summe Fremdkapital 54’118 52’892 54’394 61’335 59’623
Summe Eigenkapital 4’963 3’489 3’672 18’357 20’808
Summe Passiva 59’081 56’381 58’066 79’692 80’431

Adresse

980 Great West Road, TW8 9GS Middlesex
Telefon +44 (20) 8047-5000
Fax +44 (20) 8047-7807
URL http://gsk.com

Management

Amy Altshul
SVP-Legal, Research & Development
Anne C. Beal
Independent Non-Executive Director
Brian James McNamara
Chief Executive Officer-Consumer Healthcare
Charles A. Bancroft
Independent Non-Executive Director
Christopher Corsico
Senior Vice President-Development
David Simon Redfern
Chief Strategy Officer
Deborah Jayne Waterhouse
Member-Executive Board
Diana Conrad
Senior Vice President-Human Resources
Emma N. Walmsley
Chief Executive Officer & Executive Director
Hal V. Barron
Executive Director & Chief Scientific Officer
Iain James Mackay
Chief Financial Officer & Executive Director
James Ford
Senior Vice President & General Counsel
Jesse Goodman
Independent Non-Executive Director
Jon Ellis
VP & Head-Technology Business Development
Jonathan Richard Symonds
Non-Executive Chairman
Karenann K. Terrell
Chief Digital & Technology Officer
Kevin Sin
SVP & Head-Worldwide Business Development
Laurie H. Glimcher
Independent Non-Executive Director
Luke Miels
Chief Commercial Officer
Luke Miels
President-Global Pharmaceuticals Division
Lynn Laverty Elsenhans
Independent Non-Executive Director
Manvinder Singh Banga
Senior Independent Non-Executive Director
Marc Jones
Senior Vice President-Regional Pharma Supply
María Cristina de Luna Basagoiti
Chairman & General Manager-Spain
Maya Martinez-Davis
President-US Pharmaceuticals
Neil Barnes
Global Franchise Medical Head-Respiratory
Nick Hirons
Senior Vice President-Global Ethics & Compliance
Philip Thomson
President-Global Affairs
Rab Prinjha
Head-Epigenetics Discovery Performance Unit
Regis Jean-Pierre Simard
President-Pharmaceutical Supply Chain
Roger Connor
President-Global Vaccines
Romulo Colindres
VP-Global Medical Affairs Lead for Zoster
Sarah Elton-Farr
Head-Global Investor Relations
Sarah-Jane Hall
Group Treasurer & Senior Vice President
Seok Kian Tay
VP-Executive Compensation Strategy & Governance
Tony Wood
SVP-Platform Technology & Science
Urs Rohner
Independent Non-Executive Director
Victoria A. Whyte
Secretary
Vivienne Cox
Independent Non-Executive Director

Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen